These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The anaemia of chronic disorders. Cartwright GE; Lee GR Br J Haematol; 1971 Aug; 21(2):147-52. PubMed ID: 4934605 [No Abstract] [Full Text] [Related]
3. Disorders of iron metabolism. Diagnostic methods. Cavill I Clin Haematol; 1982 Jun; 11(2):259-73. PubMed ID: 7042152 [No Abstract] [Full Text] [Related]
4. The clinical syndromes of hyperferremia. Wilson BO; Bahu RM; Kent G Ann Clin Lab Sci (1971); 1971; 1(1):64-73. PubMed ID: 4949763 [No Abstract] [Full Text] [Related]
5. Clinical application of recombinant erythropoietin in the anemia of chronic disease. Means RT Hematol Oncol Clin North Am; 1994 Oct; 8(5):933-44. PubMed ID: 7852216 [TBL] [Abstract][Full Text] [Related]
6. Iron absorption and iron overload. Powell LA; Halliday JW Clin Gastroenterol; 1981 Sep; 10(3):707-35. PubMed ID: 7032763 [No Abstract] [Full Text] [Related]
7. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin. Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327 [TBL] [Abstract][Full Text] [Related]
8. Iron and the reticuloendothelial system. Haurani FI; Meyer A Adv Exp Med Biol; 1976; 73 PT-A():171-87. PubMed ID: 793347 [No Abstract] [Full Text] [Related]
9. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin. Kotaki M; Uday K; Henriquez M; Blum S; Dave M Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787 [No Abstract] [Full Text] [Related]
10. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients. Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771 [TBL] [Abstract][Full Text] [Related]
13. Benefits and risks of iron therapy for chronic anaemias. Weiss G; Gordeuk VR Eur J Clin Invest; 2005 Dec; 35 Suppl 3():36-45. PubMed ID: 16281957 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of storage-iron distribution in serum and reticuloendothelial system in patients with rheumatoid arthritis (author's transl)]. Fereberger W; Neubauer M; Rainer F; Robier FP Acta Med Austriaca; 1980; 7(3):88-91. PubMed ID: 7223341 [TBL] [Abstract][Full Text] [Related]
15. Erythropoietin and intravenous iron therapy in postpartum anaemia. Wågström E; Akesson A; Van Rooijen M; Larson B; Bremme K Acta Obstet Gynecol Scand; 2007; 86(8):957-62. PubMed ID: 17653881 [TBL] [Abstract][Full Text] [Related]
16. Iron metabolism and iron substitution during erythropoietin therapy. Sunder-Plassmann G; Hörl WH Clin Investig; 1994; 72(6 Suppl):S11-5. PubMed ID: 7950165 [TBL] [Abstract][Full Text] [Related]
17. Optimizing renal anaemia management--benefits of early referral and treatment. Stevens P Nephrol Dial Transplant; 2005 Sep; 20 Suppl 8():viii22-26. PubMed ID: 16079327 [TBL] [Abstract][Full Text] [Related]
18. [Conservative treatment of infection and tumor anemia]. Kubanek B Dtsch Med Wochenschr; 1979 Feb; 104(7):238-40. PubMed ID: 761512 [No Abstract] [Full Text] [Related]